Insmed Incorporated

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INSM and other ETFs, options, and stocks.

About INSM

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.

CEO

William H. Lewis

CEOWilliam H. Lewis

Employees

613

Employees613

Headquarters

Bridgewater, New Jersey

HeadquartersBridgewater, New Jersey

Founded

1988

Founded1988

Employees

613

Employees613

INSM Key Statistics

Market cap

2.92B

Market cap2.92B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.22M

Average volume1.22M

High today

—

High today—

Low today

—

Low today—

Open price

$21.08

Open price$21.08

Volume

0.00

Volume0.00

52 Week high

$28.94

52 Week high$28.94

52 Week low

$16.41

52 Week low$16.41

Analyst ratings

100%

of 13 ratings

Buy

100%

Hold

Sell

INSM Earnings

-$1.09

-$0.73

-$0.36

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

-$1.02 per share

Estimated-$1.02 per share

Actual

Expected Feb 16, Pre-Market

ActualExpected Feb 16, Pre-Market

Insmed Incorporated

Why Robinhood?

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. Show more

INSM Key Statistics

Analyst ratings

100%

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.